Roivant Sciences is a biopharmaceutical company focused on acquiring, developing, and commercializing promising drug candidates that larger firms have deprioritized. By creating nimble subsidiaries for each therapy, it accelerates treatments across neurology, immunology, and rare diseases. Patients gain faster access to innovative medicines, while investors benefit from a diversified pipeline with significant upside potential.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends